Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review.

HLA - 1 Apr 2024

Lemal Richard, Blandin Lucie, Uro-Coste Charlotte, Philipponnet Carole, Geoffroy Etienne, Heng Anne-Elisabeth, Garrouste Cyril, Rouzaire Paul

Abstract excerpt

We report data on six kidney or heart recipients who were administered daratumumab to treat or prevent antibody-mediated rejection (ABMR). To date, data are scarce concerning the use of daratumumab in solid organ transplantation and most reports show a decrease in donor-specific antigen (DSA) levels and an improvement in ABMR using a multiple myeloma daratumumab administration scheme, that is, with sequential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft Rejection

Share to HLA Antigens

Share to Isoantibodies

Share to Kidney

Share to Kidney Transplantation

Share to Transplant Recipients

Source

Identifiers

PMID: 38597238
DOI: 10.1111/tan.15458

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review.PMID 38597238Read ↗

Novel strategies to target the humoral alloimmune response.Semantic proximity Read ↗

Phenotypes of antibody-mediated rejection in organ transplants.Semantic proximity Read ↗

CAR T-cell therapy - Paving the way for sensitized kidney transplant patientsSemantic proximity Read ↗

Depletion of alloreactive B cells by chimeric alloantigen receptor T cells with drug resistance to prevent antibody-mediated rejection in solid organ transplantationSemantic proximity Read ↗

HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization.Semantic proximity Read ↗

Daratumumab monotherapy for refractory lupus nephritisSemantic proximity Read ↗

HLA antibody affinity determination: From HLA-specific monoclonal antibodies to donor HLA specific antibodies (DSA) in patient serum.Semantic proximity Read ↗

Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.Semantic proximity Read ↗

DQ molecules are the principal stimulators of<i>de novo</i>donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplantSemantic proximity Read ↗

Highly sensitised patients awaiting deceased donor renal transplants are disadvantaged by the presence of denatured HLA antibody detected in routine HLA antibody testing.Semantic proximity Read ↗

An antibody combination that targets activated T cells extends graft survival in sensitized recipients.Semantic proximity Read ↗

Cumulative mean fluorescent intensities of HLA specific antibodies predict antibody mediated rejections after kidney transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.